跳至主要内容
临床试验/EUCTR2006-005220-16-SE
EUCTR2006-005220-16-SE进行中(未招募)不适用

Cardiovascular fysiological effects of Exenatide on heart failure

Karolinska institutet0 个研究点开始时间: 2007年4月17日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1: Decompensated heart failure ( NYHA 3-4) despite optimal treatment with diuretics and ACE inhibitors/ AT II antagonists.
  • 2: Type II diabetes.
  • 3: Ejection fraction < 35%, measured by doppler echocardiografia.
  • 4: Admission to hospital.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1: Type 1 diabetes.
  • 3: Acute infection.
  • 4: Myocardial infarction or unstable angina pectoris the last 2 months before randomisation.
  • 5: Renal failure (creatinine clearence < 30 ml/min)
  • 6: Active psychiatric diease.
  • 7: Anemia ( Hb < 90 g/l)
  • 8: Pregnancy

研究者

相似试验